BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18852329)

  • 21. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
    Wang J; Sun B; Hou M; Pan X; Li X
    Int J Obes (Lond); 2013 Jul; 37(7):999-1005. PubMed ID: 23090578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue.
    Sutinen J; Kannisto K; Korsheninnikova E; Nyman T; Ehrenborg E; Andrew R; Wake DJ; Hamsten A; Walker BR; Yki-Järvinen H
    Diabetologia; 2004 Oct; 47(10):1668-71. PubMed ID: 15455200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
    Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
    Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
    Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
    Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
    Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
    Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S
    J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M; Seckl JR
    Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
    Tomlinson JW
    Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity.
    Basu R; Edgerton DS; Singh RJ; Cherrington A; Rizza RA
    Diabetes; 2006 Nov; 55(11):3013-9. PubMed ID: 17065337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization.
    Nixon M; Wake DJ; Livingstone DE; Stimson RH; Esteves CL; Seckl JR; Chapman KE; Andrew R; Walker BR
    Diabetes; 2012 Apr; 61(4):790-6. PubMed ID: 22357964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.
    Sandeep TC; Andrew R; Homer NZ; Andrews RC; Smith K; Walker BR
    Diabetes; 2005 Mar; 54(3):872-9. PubMed ID: 15734867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver is the site of splanchnic cortisol production in obese nondiabetic humans.
    Basu R; Basu A; Grudzien M; Jung P; Jacobson P; Johnson M; Singh R; Sarr M; Rizza RA
    Diabetes; 2009 Jan; 58(1):39-45. PubMed ID: 18852327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
    Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
    Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men.
    Stimson RH; Johnstone AM; Homer NZ; Wake DJ; Morton NM; Andrew R; Lobley GE; Walker BR
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4480-4. PubMed ID: 17785367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vivo microdialysis coupled with liquid chromatography/tandem mass spectrometry study of cortisol metabolism in monkey adipose tissue.
    Sun L; Stenken JA; Brunner JE; Michel KB; Adelsberger JK; Yang AY; Zhao JJ; Musson DG
    Anal Biochem; 2008 Oct; 381(2):214-23. PubMed ID: 18638442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.